Trial Profile
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2023
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Asthenia
- Focus Therapeutic Use
- Acronyms PREPARE
- 08 Aug 2023 Status changed from active, no longer recruiting to completed.
- 18 Apr 2023 Planned End Date changed from 24 Feb 2023 to 31 Jul 2023.
- 18 Apr 2023 Planned primary completion date changed from 24 Feb 2023 to 31 Jul 2023.